Conversion from regional to systemic chemotherapy.
Hepatic artery chemotherapy for the ambulatory patient using the Infusaid pump has been advocated for the management of malignant hepatic disease. Catheter related complications remain a potential source of morbidity particularly when the transaxillary approach is used. Should hepatic artery catheter related complications arise, the possibility of conversion to a systemic route offers the opportunity to salvage the Infusaid pump.
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002404:Catheterization / Q000295:instrumentation; D003110:Colonic Neoplasms / Q000188:drug therapy*; D006499:Hepatic Artery; D006801:Humans; D007260:Infusion Pumps; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D012004:Rectal Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents